CORTICOTROPIN-RELEASING HORMONE PHYSIOLOGY
促肾上腺皮质激素释放激素生理学
基本信息
- 批准号:3231739
- 负责人:
- 金额:$ 18.46万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1983
- 资助国家:美国
- 起止时间:1983-12-01 至 1990-06-30
- 项目状态:已结题
- 来源:
- 关键词:Cushing's syndrome arginine vasopressin chromatography corticotropin releasing factor endocrine disorder diagnosis fluorescent dye /probe glucocorticoids hormone regulation /control mechanism human subject orphan disease /drug peptide hormone metabolism perfusion pituitary adrenal axis pituitary neoplasms proopiomelanocortin radioimmunoassay
项目摘要
The overall objective of this research project is to define further
the normal and abnormal physiology of corticotropin-releasing
hormone (CRH). The efficacy of CRH stimulation during bilateral
inferior petrosal vein sampling for plasma immunoreactive (IR)
ACTH as a diagnostic test for differentiating Cushing's disease
from ectopic ACTH syndrome and/or lateralizing pituitary
microadenomas causing Cushing's disease will be evaluated. The
intraoperative use of a fluorescent analog of human CRH (hCRH)
to identify ACTH-secreting microadenomas either after they have
been removed or in situ will be explored in vitro with excised
human pituitary tumor tissue and in vivo in animals prior to
possible clinical trials. A high molecular weight "IR-hCRH" in
plasma, which may be an aggregate, a precursor, an hCRH-
degrading enzyme or a specific carrier protein, will be
characterized, and its effect on CRH bioactivity will be
determined. The possible proliferative effects of chronic
exposure to CRH on pituitary corticotrophs will be investigated in
vivo in an animal model in which ovine CRH is infused
intracerebroventricularly, and in vitro in dispersed rat anterior
pituitary cell cultures. The fine temporal features of regulation
of ACTH secretion by CRH and other agonists and antagonists of
ACTH secretion and the interactions between the intracellular
signal transduction pathways that mediate the actions of CRH,
arginine vasopressin and other modulators of ACTH secretion will
be elucidated in a dispersed cell microperifusion column system.
这个研究项目的总体目标是进一步定义
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DAVID N ORTH其他文献
DAVID N ORTH的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DAVID N ORTH', 18)}}的其他基金
NORMAL AND ABNORMAL HYPOTHALAMIC PITUITARY ADRENAL FUNCTION IN CUSHINGS
库欣的正常和异常下丘脑垂体肾上腺功能
- 批准号:
6246691 - 财政年份:1997
- 资助金额:
$ 18.46万 - 项目类别:
CRH'S ROLE IN CAUSE AND RECOVERY FROM HYPERCORTISOLISM
CRH 在皮质醇增多症的病因和恢复中的作用
- 批准号:
2145276 - 财政年份:1994
- 资助金额:
$ 18.46万 - 项目类别:
CRH'S ROLE IN CAUSE AND RECOVERY FROM HYPERCORTISOLISM
CRH 在皮质醇增多症的病因和恢复中的作用
- 批准号:
2145277 - 财政年份:1994
- 资助金额:
$ 18.46万 - 项目类别:
CRH'S ROLE IN CAUSE AND RECOVERY FROM HYPERCORTISOLISM
CRH 在皮质醇增多症的病因和恢复中的作用
- 批准号:
2145275 - 财政年份:1994
- 资助金额:
$ 18.46万 - 项目类别:
POMC PEPTIDE SYNTHESIS BY NORMAL AND AIDS LEUKOCYTES
正常和艾滋病白细胞合成 POMC 肽
- 批准号:
3241618 - 财政年份:1989
- 资助金额:
$ 18.46万 - 项目类别:
POMC PEPTIDE SYNTHESIS BY NORMAL AND AIDS LEUKOCYTES
正常和艾滋病白细胞合成 POMC 肽
- 批准号:
3241616 - 财政年份:1989
- 资助金额:
$ 18.46万 - 项目类别:
POMC PEPTIDE SYNTHESIS BY NORMAL AND AIDS LEUKOCYTES
正常和艾滋病白细胞合成 POMC 肽
- 批准号:
3241617 - 财政年份:1989
- 资助金额:
$ 18.46万 - 项目类别:
CORTICOTROPIN-RELEASING FACTOR--HUMAN PHYSIOLOGY
促肾上腺皮质激素释放因子--人体生理学
- 批准号:
3152791 - 财政年份:1983
- 资助金额:
$ 18.46万 - 项目类别:
相似海外基金
PET ligand discovery for arginine vasopressin
精氨酸加压素的 PET 配体发现
- 批准号:
10641669 - 财政年份:2022
- 资助金额:
$ 18.46万 - 项目类别:
PET ligand discovery for arginine vasopressin
精氨酸加压素的 PET 配体发现
- 批准号:
10356395 - 财政年份:2022
- 资助金额:
$ 18.46万 - 项目类别:
Role of arginine-vasopressin and V1A receptor in psychosocial stress-induced myocardial injury
精氨酸加压素和 V1A 受体在心理应激诱发的心肌损伤中的作用
- 批准号:
10671052 - 财政年份:2021
- 资助金额:
$ 18.46万 - 项目类别:
Role of arginine-vasopressin and V1A receptor in psychosocial stress-induced myocardial injury
精氨酸加压素和 V1A 受体在心理应激诱发的心肌损伤中的作用
- 批准号:
10470346 - 财政年份:2021
- 资助金额:
$ 18.46万 - 项目类别:
Role of arginine-vasopressin and V1A receptor in psychosocial stress-induced myocardial injury
精氨酸加压素和 V1A 受体在心理应激诱发的心肌损伤中的作用
- 批准号:
10283131 - 财政年份:2021
- 资助金额:
$ 18.46万 - 项目类别:
Physiological role of arginine vasopressin released from RGCs on circadian rhythm and psychiatry function
RGC 释放的精氨酸加压素对昼夜节律和精神功能的生理作用
- 批准号:
19K06939 - 财政年份:2019
- 资助金额:
$ 18.46万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Identification of mechanisms of arginine vasopressin receptor 1A in peripheral neuropathic pain
精氨酸加压素受体 1A 在周围神经病理性疼痛中的作用机制的鉴定
- 批准号:
18K16609 - 财政年份:2018
- 资助金额:
$ 18.46万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Functional mapping of arginine vasopressin receptor 1A circuits that promote anorexic behavior
促进厌食行为的精氨酸加压素受体 1A 电路的功能图谱
- 批准号:
10321547 - 财政年份:2018
- 资助金额:
$ 18.46万 - 项目类别:
Usefulness of arginine vasopressin levels on admission in risk stratification of acute decompensated heart failure with preserved left ventricular ejection fraction
入院时精氨酸加压素水平在左心室射血分数保留的急性失代偿性心力衰竭风险分层中的作用
- 批准号:
16K09448 - 财政年份:2016
- 资助金额:
$ 18.46万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Variation in the arginine vasopressin 1a receptor (AVPR1a) gene, the social environment, general health and wellbeing
精氨酸加压素 1a 受体 (AVPR1a) 基因的变异、社会环境、总体健康和福祉
- 批准号:
DP130100612 - 财政年份:2013
- 资助金额:
$ 18.46万 - 项目类别:
Discovery Projects